|
|
|
|
| LEADER |
01000caa a2200265 4500 |
| 001 |
OLC1988932688 |
| 003 |
DE-627 |
| 005 |
20230511115640.0 |
| 007 |
tu |
| 008 |
170207s2017 xx ||||| 00| ||eng c |
| 024 |
7 |
|
|a 10.1097/QAD.0000000000001275
|2 doi
|
| 028 |
5 |
2 |
|a PQ20170301
|
| 035 |
|
|
|a (DE-627)OLC1988932688
|
| 035 |
|
|
|a (DE-599)GBVOLC1988932688
|
| 035 |
|
|
|a (PRQ)c1501-a5319d5c183b9dc50a5b15d8bf4db8a55b2c49faac6110c5f937794d5e5c4510
|
| 035 |
|
|
|a (KEY)0157957620170000031000100175increaseininternationalnormalizedratioafterswitchi
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 084 |
|
|
|a XA 16838
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.78
|2 bkl
|
| 100 |
1 |
|
|a Tseng, Alice L
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal
|
| 264 |
|
1 |
|c 2017
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 540 |
|
|
|a Nutzungsrecht: Copyright © 2017 Wolters Kluwer Health, Inc.
|
| 700 |
1 |
|
|a Luetkehoelter, Jonathan
|4 oth
|
| 700 |
1 |
|
|a Walmsley, Sharon L
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Aids <London>
|d Hagerstown, Md. : Lippincott Williams & Wilkins, 1987
|g 31(2017), 1, Seite 175-176
|w (DE-627)168132583
|w (DE-600)639076-6
|w (DE-576)015929418
|x 0269-9370
|7 nnns
|
| 773 |
1 |
8 |
|g volume:31
|g year:2017
|g number:1
|g pages:175-176
|
| 856 |
4 |
1 |
|u http://dx.doi.org/10.1097/QAD.0000000000001275
|3 Volltext
|
| 856 |
4 |
2 |
|u http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00002030-201701020-00021
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_2414
|
| 912 |
|
|
|a GBV_ILN_4125
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
r |
v |
|a XA 16838
|
| 936 |
b |
k |
|a 44.78
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 31
|j 2017
|e 1
|h 175-176
|
